Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial [NA]
A clinical trial update indicates the Comprehensive Radiobiology Assessment trial examining microenvironment effects of radiotherapy is curr…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating a recombinant EphB4-HSA fusion protein in combination with standard chemotherapy for advanced or metastatic solid t…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers [NA]
A clinical trial examining telehealth self-management coaching to improve quality of life for pancreatic cancer survivors and their family c…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer [NA]
This is an update on the PancFit trial, a multimodal exercise program during preoperative therapy for pancreatic cancer, which is currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: GENetic Education Risk Assessment and TEsting Study [NA]
An active-not-recruiting clinical trial at Dana-Farber Cancer Institute evaluating genetic education, risk assessment, and testing for hered…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This update reports results from a Phase 1/2 trial of ABT-888 (veliparib) in combination with a modified FOLFOX6 regimen for metastatic panc…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports termination of NUV-868 as monotherapy and in combination with olaparib or enzalutamide in adults with adva…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery [Phase 1]
A Phase 1 trial evaluating an investigational neoantigen vaccine for pancreatic cancer has completed, exploring the vaccine in the pre-surgi…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region [NA]
This document provides an update on a completed clinical trial evaluating respiratory-gated SBRT for pancreatic adenocarcinoma and periampul…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the safety, tolerability, and efficacy of the modified FOLFIRINOX regimen with or without BNT321 as adjuvant ther…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors [Phase 2]
A Phase 2 trial evaluating niraparib in patients with advanced PALB2-mutated tumors was terminated; results have been posted for multiple so…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Clinical trial SYNERGY-AI is an AI-based precision oncology matching and registry study sponsored by Massive Bio, currently recruiting acros…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I [Phase 1]
Phase I trial evaluating gemcitabine with ascorbate (vitamin C) and radiation therapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? [Phase 3]
Phase 3 trial evaluating whether cefoxitin or piperacillin-tazobactam prophylaxis prevents postoperative surgical site infections after panc…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients [NA]
A Memorial Sloan Kettering Cancer Center study to develop educational materials about genetic testing for a diverse group of cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses [NA]
This clinical trial update indicates completion and results posting for a study of stereotactic radiotherapy using varying biological effect…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors [Phase 1]
Phase Ib study evaluating a combination of metformin, digoxin, and simvastatin in advanced pancreatic cancer and other solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC [Phase 2]
A Phase 2 trial evaluating Ampligen plus standard of care versus standard of care alone for locally advanced pancreatic cancer has been susp…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers [Phase 1]
A Phase 1 study of AMG 199 in MUC17-positive solid tumors including gastric, gastroesophageal junction, colorectal, and pancreatic cancers h…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of BMS-813160 in combination with chemotherapy or nivolumab for advanced solid tumors has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: The Cancer of the Pancreas Screening-5 CAPS5)Study [Phase 3]
A Phase 3 clinical trial led by Johns Hopkins University is currently recruiting participants to screen for pancreatic cancer in Peutz-Jeghe…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma [NA]
A ClinicalTrials.gov listing for a study comparing preoperative fractionated radiation therapy versus stereotactic body radiation therapy in…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
This clinical trial update describes a study evaluating detection of tumor cells and tumor DNA in blood, urine, and bone marrow across multi…